Rheumatoid arthritis

Area of Science:

• Immunology
• Rheumatology
• Autoimmune Diseases

Background:

• Rheumatoid arthritis (RA) is a chronic, multisystemic inflammatory disease of unknown cause.
• It primarily affects peripheral joints symmetrically, leading to deformity and disability.
• Tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) are key inflammatory mediators in RA pathogenesis.

Purpose of the Study:

• To summarize the current understanding of rheumatoid arthritis pathophysiology.
• To highlight diagnostic markers and prognostic factors in RA.
• To emphasize the impact of early diagnosis and targeted therapy on RA outcomes.

Main Methods:

• Literature review of rheumatoid arthritis pathophysiology.
• Analysis of diagnostic criteria and prognostic indicators.
• Evaluation of treatment strategies and their impact on disease course.

Main Results:

• RA etiology remains unknown despite advances in understanding its autoimmune nature.
• Anti-citrullinated peptide antibodies aid in diagnosing undifferentiated polyarthritis and predict aggressive RA.
• RA natural history includes joint damage, disability, and reduced life expectancy due to comorbidities.

Conclusions:

• Early diagnosis of rheumatoid arthritis is crucial for effective management.
• Targeted therapies aimed at inducing remission significantly improve RA prognosis.
• Understanding RA's inflammatory pathways, like TNF-α and IL-6, is key to developing new treatments.